NEW YORK CITY, NY / ACCESS Newswire / May 16, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Senti Biosciences, Inc. ("Senti" or "the Company") (NASDAQ
NTI). Investors who purchased Senti securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SNTI.
